IndraLab

Statements


2 | 6 6

sparser
"IP experiments showed that USP33 interacted with c-Myc ( xref ), and USP33 knockdown profoundly enhanced c-Myc ubiquitination ( xref )."

sparser
"These data suggested that USP33 may bind and deubiquitinate c-Myc in 22RV1 cells."

No evidence text available

sparser
"IP experiments revealed that USP33 could bind and deubiquitinate c-Myc."

sparser
"USP33 can bind to c-Myc."

reach
"USP33 could bind and deubiquitinate c-Myc."

reach
"IP experiments showed that USP33 interacted with c-Myc (XREF_FIG), and USP33 knockdown profoundly enhanced c-Myc ubiquitination (XREF_FIG)."

reach
"These data suggested that USP33 may bind and deubiquitinate c-Myc in 22RV1 cells."

reach
"IP experiments revealed that USP33 could bind and deubiquitinate c-Myc."

sparser
"Clinically, high USP33 expression correlates with poor prognosis, suggesting that the USP33-c-Myc axis may serve as both a prognostic biomarker and a potential therapeutic target."

reach
"USP33, as a deubiquitinating enzyme, can bind and deubiquitinate c-Myc, thereby promoting the proliferation and cell cycle progression of PCa cells and reducing their sensitivity to DTX [70]."

reach
"USP33 can bind to c-Myc."

sparser
"USP33 could bind and deubiquitinate c-Myc."

No evidence text available